Oral Candidiasis (Thrush)

1. Executive Overview: Understanding Oral Candidiasis (ICD-10: B37.0)

Oral Candidiasis, commonly referred to as oral thrush, is a clinical manifestation of a fungal infection of the oropharyngeal mucosa. It is primarily caused by the overgrowth of Candida albicans, a commensal yeast that resides in the oral cavity, gastrointestinal tract, and vaginal mucosa of a significant percentage of the healthy population. While C. albicans is the most common pathogen, other species such as C. glabrata, C. tropicalis, and C. krusei are increasingly identified in immunocompromised patients.

In a state of homeostasis, the oral microbiome, salivary flow, and the host’s immune system maintain Candida in a dormant, commensal state. However, when the host’s local or systemic defenses are compromised—whether through antibiotic usage, immunosuppression, or xerostomia—the yeast undergoes a morphological transition from yeast to hyphal form, leading to tissue invasion and clinical disease. Recognizing this condition early is vital, as it can serve as a sentinel marker for underlying systemic diseases, including diabetes mellitus, hematologic malignancies, or HIV/AIDS.

2. Pathophysiology, Etiology, and Risk Factors

The pathogenesis of oral candidiasis is multifactorial, involving an intricate interplay between host immune mechanisms and the virulence factors of the Candida species.

The Mechanism of Infection

Candida albicans is a polymorphic fungus. Its ability to switch phenotypes is its primary virulence factor. The transition from the yeast form to the hyphal form allows the organism to penetrate the epithelial layers, secrete enzymes (such as aspartyl proteinases and phospholipases), and cause tissue destruction.

Etiological Factors

1. Microbial Imbalance: Broad-spectrum antibiotics reduce the bacterial flora that normally compete with Candida for nutrients and adhesion sites.
2. Immune Suppression: T-cell mediated immunity is the primary defense against mucosal candidiasis. Consequently, patients with depressed cell-mediated immunity (e.g., HIV, organ transplant recipients, chemotherapy patients) are at high risk.
3. Local Factors: Reduced salivary flow (xerostomia) removes the protective effects of salivary proteins, histatins, and immunoglobulins.

High-Risk Groups

3. Signs, Symptoms, and Clinical Presentation

Oral candidiasis is not a monolithic condition; it presents in several clinical forms depending on the host response and the site of infection.

Classification of Clinical Presentations

• Pseudomembranous Candidiasis (Thrush): The most recognizable form. It presents as white, curd-like plaques that can be wiped away, leaving an erythematous, sometimes bleeding base. These plaques consist of desquamated epithelial cells, fibrin, and fungal hyphae.
• Erythematous (Atrophic) Candidiasis: Characterized by red, raw-looking areas on the tongue (often associated with "antibiotic sore mouth") or the palate.
• Chronic Hyperplastic Candidiasis: Appears as white, non-wipeable patches. This form is clinically concerning as it may represent a pre-malignant lesion (leukoplakia) colonized by Candida.
• Angular Cheilitis: Fissuring and inflammation at the corners of the mouth, often secondary to moisture accumulation and Candida or Staphylococcus aureus colonization.

Symptomatology

Patients often report a "cottony" feeling in the mouth, loss of taste (dysgeusia), pain during deglutition, and persistent burning sensations. In severe cases, the infection may extend to the esophagus, causing retrosternal pain and dysphagia.

4. Standard Diagnostic Evaluation & Workup

A definitive diagnosis of oral candidiasis requires clinical assessment supplemented by laboratory confirmation.

Diagnostic Criteria

1. Clinical Examination: Visual inspection remains the initial step. The ability to wipe off white plaques is a classic clinical indicator.
2. Microscopic Examination (KOH Prep): A smear is taken from the lesion and treated with potassium hydroxide (KOH). Under microscopy, this reveals the hallmark fungal hyphae and pseudohyphae.
3. Culture: Sabouraud’s dextrose agar is the gold standard for culturing Candida. This is essential for identifying the specific species and performing antifungal sensitivity testing (AST), especially in recurrent or refractory cases.
4. Biopsy: Indicated only for chronic hyperplastic lesions to rule out squamous cell carcinoma. Histopathology will show fungal elements invading the stratum corneum.
5. Systemic Workup: If the patient has no obvious local cause (e.g., inhaler use), clinicians should order a fasting blood glucose, HbA1c, and a complete blood count to rule out undiagnosed diabetes or anemia.

5. Therapeutic Interventions

Treatment of oral candidiasis involves a two-pronged approach: managing the underlying predisposing factors and utilizing antifungal pharmacotherapy.

Pharmacological Regimens

The treatment choice depends on the severity of the infection and the patient’s immune status.

• Topical Antifungals (First-line for mild cases):
  • Nystatin Oral Suspension: 400,000 to 600,000 units swished and swallowed four times daily.
  • Clotrimazole Troches: 10mg lozenges dissolved slowly in the mouth five times daily.
• Systemic Antifungals (For severe or refractory cases):
  • Fluconazole: 100–200mg orally once daily for 7–14 days. Fluconazole is highly effective due to its systemic distribution and high salivary concentration.
• Denture Hygiene: For denture-associated stomatitis, the prosthesis must be disinfected daily using chlorhexidine or dilute sodium hypochlorite.

Lifestyle and Preventive Measures

1. Oral Hygiene: Brushing with a soft-bristled toothbrush and using alcohol-free mouthwashes.
2. Inhaler Technique: Patients using inhaled corticosteroids must rinse their mouths with water immediately after each use.
3. Dietary Adjustments: Reducing refined carbohydrate intake may lower the fungal load in the oral cavity.
4. Probiotics: Emerging evidence suggests that certain Lactobacillus strains may help restore oral microbial balance.

6. Frequently Asked Questions (FAQ)

1. Is oral thrush contagious?
Generally, no. Candida is a normal part of the oral flora. It only becomes an infection when your body's defenses are lowered. However, it can be transmitted to immunocompromised individuals or infants.

2. How long does it take for thrush to clear up with medication?
With proper adherence to antifungal therapy, symptoms usually begin to subside within 48 to 72 hours, and the infection typically clears within 7 to 14 days.

3. Can poor dental hygiene cause thrush?
Yes. Poor hygiene, particularly in denture wearers, provides a surface for Candida to adhere and form a biofilm, leading to chronic infection.

4. Why does my thrush keep coming back?
Recurrent candidiasis often indicates an underlying systemic issue (such as undiagnosed diabetes) or a failure to treat the reservoir of infection (e.g., not cleaning dentures or inhaler mouthpieces).

5. Should I stop using my asthma inhaler if I get thrush?
No. Never stop prescribed medication without consulting your doctor. Instead, rinse your mouth thoroughly with water after every use of your inhaler.

6. Can I use salt water to treat oral thrush?
Salt water rinses can soothe the inflammation and help maintain oral hygiene, but they will not kill the fungus. Antifungal medication is required to resolve the infection.

7. Is oral thrush painful?
Many patients experience a burning sensation or pain, especially when eating or drinking acidic or spicy foods.

8. What happens if oral thrush is left untreated?
The infection can spread to the esophagus (esophageal candidiasis), causing difficulty swallowing. In immunocompromised patients, it can potentially enter the bloodstream, leading to systemic candidemia.

9. Can I drink coffee while having oral thrush?
It is recommended to avoid hot, acidic, or highly seasoned foods, as these can irritate the already inflamed oral mucosa.

10. Do I need to see a dentist or a doctor?
A dentist is often the first to diagnose oral candidiasis during a routine exam. However, if the infection is persistent or widespread, a referral to an oral medicine specialist or an infectious disease physician is appropriate.

Prognosis: The prognosis for oral candidiasis is excellent with appropriate diagnosis and treatment. In healthy individuals, it is a self-limiting or easily treated condition. In immunocompromised patients, the prognosis is dependent on the management of the underlying systemic condition. Consistent follow-up and maintenance of oral hygiene are the cornerstones of preventing recurrence.

Related Clinical Integration

In a modern clinical setting, the management of oral candidiasis requires a comprehensive approach that bridges acute pharmacological intervention with broader systemic health considerations. Clinicians should prioritize the administration of Fluconazole / فلوكونازول 150 mg as a targeted antifungal therapy to resolve localized fungal overgrowth. Furthermore, because persistent or recurrent oral thrush can serve as a clinical marker for underlying immunocompromise, it is essential for practitioners to maintain a high index of suspicion regarding systemic conditions, including HIV, which is discussed in the context of broader clinical management and surgical considerations in the ABOS Part I Orthopedic Review: Olecranon, Ankle Syndesmosis, HIV Arthroplasty | Part 22146. Integrating these resources ensures that the diagnostic process extends beyond symptomatic relief to address the patient’s overall immunological status and long-term health outcomes.